Biomedical Microdevices

, Volume 6, Issue 2, pp 113–116 | Cite as

Molecular Imaging Applications in Nanomedicine

  • King C.P. Li
  • Sunil D. Pandit
  • Samira Guccione
  • Mark D. Bednarski
Article

Abstract

The purpose of this article is to explore how molecular imaging techniques can be used as useful adjunts in the development of “nanomedicine” and in personalizing treatment of patients. The discussion focuses on in vivo applications at the whole organism level even though imaging can also play an important role in research at the cellular and subcellular level.

molecular imaging nanomedicine targeted therapy personalized treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    K.C. Li, Acad. Radiol. 9, 999–1003 (2002).Google Scholar
  2. 2.
    J. Drews and S. Ryser, Nature Biotechnol. 15, 1318–1319 (1997).Google Scholar
  3. 3.
    A.M. Hillery, in Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists, edited by A.M. Hillery, A.W. Lloyd and J. Swarbrick (Taylor & Francis, London, UK, 2001), pp. 1–48.Google Scholar
  4. 4.
    A. Bischof Delaloye, Semin. Nucl. Med. 30, 186–194 (2000).Google Scholar
  5. 5.
    D.M. Goldenberg, Cancer 80(suppl 12), 2431–2435 (1997).Google Scholar
  6. 6.
    T. Coons, Radiol. Technol. 67, 39–60 (1995).Google Scholar
  7. 7.
    G.S. Ginsburg and J.J. McCarthy, Trends Biotechnol. 19, 491–496 (2001).Google Scholar
  8. 8.
    G.D. Luker and D. Piwnica-Worms, Acad. Radiol. 8, 4–14 (2001).Google Scholar
  9. 9.
    E. Krenning, D. Kwekkeboom, W. Bakker, W.A. Breeman, P.P. Kooij, H.Y. Oei, M. van Hagen, P.T. Postema, M. de Jong, and J.C. Reubi, Eur. J. Nucl. Med. 20, 716–731 (1993).Google Scholar
  10. 10.
    G. Jerusalem, R. Hustinx, Y. Beguin, and G. Fillet, Eur. J. Cancer 39, 1525–1534 (2003).Google Scholar
  11. 11.
    C. Hoekstra, I. Paglianiti, O. Hoekstra, E.F. Smit, P.E. Postmus, G.J. Teule, and A.A. Lammerstsma, Eur. J. Nucl. Med. 27, 731–743 (2000).Google Scholar
  12. 12.
    N. Carrasco, Biochim. Biophys. Acta. 1154, 65–82 (1993).Google Scholar
  13. 13.
    J.G. Tjuvajev, A. Joshi, J. Callegari, L. Lindsley, R. Joshi, J. Balatoni, R. Finn, S.M. Larson, M. Sadelan, and R.G. Blasberg, Neoplasia 4, 315–320 (1999).Google Scholar
  14. 14.
    J.P. Northrop, M. Bednarski, S.O. Barbieri, A.T. Lu, D. Nguyen, J. Varadaraja, M. Osen, K.C. Li, and J. Star-Lack, Eur. J. Nucl. Med. Mol. Imaging 30, 1292–1298 (2003).Google Scholar
  15. 15.
    A.R. Padhani, J. Magn. Reson. Imaging 16, 407–422 (2002).Google Scholar
  16. 16.
    G.D. Demetri, M. von Mehren, C.D. Blanke, A.D. Van den Abbele, B. Eisenberg, P.J. Roberts, M.C. Heinrich, D.A. Tuveson, S. Singer, M. Janicek, J.A. Fletcher, S.G. Silverman, S.L. Silberman, R. Capdeville, B. Kiese, B. Peng, S. Dimitrijevic, B.J. Druker, C. Corless, C.D. Fletcher, and H. Joensuu, N. Engl. J. Med. 347, 472–480 (2002).Google Scholar
  17. 17.
    K.C.P. Li (Guest Editor), J. Magn. Reson. Imaging 16, 333–483 (2002).Google Scholar
  18. 18.
    R.G. Blasberg and J.G. Tjuvajev, J. Clin. Invest. 111, 1620–1629 (2003).Google Scholar
  19. 19.
    T.F. Massoud and S.S. Gambhir, Genes and Development 17, 545–580 (2003).Google Scholar
  20. 20.
    H.C. Loughrey, L.S. Choi, K.F. Wong, P.R. Cullis, and M.B. Bally, in Liposome Technology, edited by G. Gregoriadis, Vol. III (CRC Press, London, 1993), pp. 163–177.Google Scholar
  21. 21.
    J.H. Senior, Crit. Rev. Therap. Drug Carrier Syst. 3, 123–193 (1987).Google Scholar
  22. 22.
    A.A. Gabizon, Cancer Invest. 19, 424–436 (2001).Google Scholar
  23. 23.
    R.W. Storrs, F.D. Tropper, H.Y. Li, C.K. Song, J.K. Kuniyoshi, D.A. Sipkins, K.C.P. Li, and M.D. Bednarski, J. Am. Chem. Soc. 117, 7301–7306 (1995).Google Scholar
  24. 24.
    G. Bergers and L.E. Benjamin, Nat. Rev. Cancer 3, 401–410 (2003).Google Scholar
  25. 25.
    R.K. Jain, L.L. Munn, and D. Fukumura, Nat. Rev. Cancer 2, 266–276 (2003).Google Scholar
  26. 26.
    K. Greish, J. Fang, T. Inutsuka, A. Kagamitsu, and H. Maeda, Clin. Pharmacokinet. 42, 1089–1105 (2003).Google Scholar
  27. 27.
    D.M. McDonald and P. Baluk, Cancer Res. 62, 5381–5385 (2002).Google Scholar
  28. 28.
    S.D. Conner and S.L. Schmid, Nature 422, 37–44 (2003).Google Scholar
  29. 29.
    R. Savic, L. Luo, A. Eisenberg, and D. Maysinger, Science 300, 615–618 (2003).Google Scholar
  30. 30.
    R.W. Storrs, F.D. Tropper, H.Y. Li, C.K. Song, D.A. Sipkins, J.K. Kuniyoshi, M.D. Bednarski, H.W. Strauss, and K.C. Li, J. Magn. Reson. Imaging 5, 719–724 (1995).Google Scholar
  31. 31.
    D.A. Sipkins, D.A. Cheresh, M.R. Kazemi, L.M. Nevin, M.D. Bednarski, and K.C.P. Li, Nat. Med. 4, 623–626 (1998).Google Scholar
  32. 32.
    J.D. Hood, M.D. Bednarski, R. Frausto, S. Guccione, R.A. Reisfeld, R. Xiang, and D.A. Cheresh, Science 296, 2404–2407 (2002).Google Scholar
  33. 33.
    P. Carmeliet, Nat. Med. 9, 653–660 (2003).Google Scholar
  34. 34.
    G. Kong, R.D. Braun, and M.W. Dewhirst, Cancer Res. 61, 3027–3032 (2001).Google Scholar
  35. 35.
    J.L. Nelson, B.L. Roeder, J.C. Carmen, F. Roloff, and W.G. Pitt, Cancer Res. 62, 7280–7283 (2002).Google Scholar
  36. 36.
    M.D. Bednarski, J.W. Lee, M.R. Callstrom, and K.C. Li, Radiology 204, 263–268 (1997).Google Scholar
  37. 37.
    Who'd want to work in a team? Nature 424, 1 (2003).Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • King C.P. Li
    • 1
  • Sunil D. Pandit
    • 1
  • Samira Guccione
    • 1
  • Mark D. Bednarski
    • 1
  1. 1.Clinical CenterNational Institutes of HealthBethesda

Personalised recommendations